Dr A. Malaspina at Queen Mary University of London is leading a multi-centre study with 5 recruitment centres within and outside London. The main goal is to establish a biological repository that covers the natural history of the disease and provides the experimental platform to test novel biomarkers to evaluate prognosis and treatment response in affected individuals and to help develop clinical trials. The study has already delivered a better understanding of how the disease can be monitored and characterized using simple assays for the determination of protein levels in blood.
Any patient with ALS or with other neurological conditions as well as healthy individuals willing to take part in the study should use the following contacts:
Tel: 0203 594 1883
Fax: 0203 594 2153